slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
191,941-192,000 of 319,975
44
The table uses checkmarks and X marks to denote presence or absence of specific clinical benefits/side effects.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
45
The right-hand diagram is a stylized funnel/segmentation representation of the addressable market.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
46
The slide uses a pharmacokinetic line chart to demonstrate rapid absorption and a bulleted list to summarize clinical efficacy in GAD and panic models.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
47
The slide uses a bar chart to compare placebo vs BNC210 across two metrics: total number of symptoms and symptom intensity.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
48
The slide outlines a specific clinical trial protocol involving 24 GAD patients.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
49
Includes references to specific clinical studies and behavioral tasks (JORT).Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
50
The slide uses a process flow diagram to illustrate the clinical trial methodology.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
51
The slide details the research rigor behind the market sizing/revenue projections.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
52
The slide uses a flow-chart style to represent patient movement between treatment lines.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
53
Includes qualitative feedback from psychiatrists alongside key findings.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
54
Includes qualitative testimonials from psychiatrists to support the adoption thesis.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
55
The slide uses a hierarchical decomposition framework to show how revenue is derived from epidemiological and commercial assumptions.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
56
The chart displays a steady growth trajectory for the drug's revenue.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
57
The slide uses a list-based framework to highlight five key pillars of the drug's value proposition.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
58
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
59
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
01
BlackRock | Results Presentation Deck | 12 slidesBlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations 1 hit
02
The slide uses stacked bar charts to compare AUM vs Base Fees for four different business segments.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Business Model1 hit
03
The slide uses a combination of stacked bar charts and circular indicators for growth rates. The legend distinguishes between Long-term, Cash, Advisory, Institutional Active, and Institutional Index flows.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Business Model1 hit
04
Includes a disclaimer regarding GAAP reconciliations and definition updates.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Financials1 hit
05
The slide uses a combination of bar charts for repurchases/dividends and a line chart for share counts.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Financials1 hit
06
Data sourced from Bloomberg; includes a specific note regarding the BLK Equity Index calculation methodology.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Financials1 hit
07
The slide uses two waterfall charts to bridge the revenue change between periods.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Financials1 hit
08
The slide uses two waterfall charts to bridge the revenue changes between periods.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Financials1 hit
09
Includes two waterfall charts comparing Q3 2022 to Q3 2021 and Q2 2022, plus a summary table of percentage changes.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Financials1 hit
10
Includes a memo section for liquid credit and detailed definitions at the bottom.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations Beat · Market Size1 hit
11
Includes a detailed footnote regarding updated definitions of operating income and non-GAAP adjustments starting in Q1 2022.BlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations 1 hit
12
BlackRock | Results Presentation Deck | 12 slidesBlackRock | Results Presentation Deck | 12 slides · BlackRock
Conference presentation Investor relations 1 hit
01
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations 1 hit
02
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations 1 hit
03
Uses a before-after-bridge style structure to contrast vaccine efficacy with remaining clinical challenges.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide displays two forest plots showing confidence intervals for vaccine effectiveness across multiple studies.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide describes the mechanism of action for a specific vaccine candidate (BHN97ΔftsY).Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · AgitateLoop · Jobs To Be Done1 hit
07
The slide presents experimental data from a study on live-attenuated pneumococcal vaccines.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
The slide presents preclinical data comparing a vaccine candidate (BHN97ΔftsY) against a control (Mock) and a standard (PCV13).Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
09
The slide presents three sets of survival plots (Kaplan-Meier style) and corresponding bacterial load scatter plots for three different serotype challenges.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
10
The slide uses bioluminescence imaging to visualize bacterial load in the ear region of mice.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
11
Data presented as scatter plots with horizontal bars indicating means; statistical significance markers included.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
12
The diagram uses question marks to represent the unknown or challenging nature of integrating different protein types into the central platform.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
13
The data shows ELISA absorbance results comparing vehicle (PBS) to the vaccine construct (LAV-D-M1) across four different pathogen serotypes/species.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
14
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
15
Blue Water Vaccines | Results Presentation Deck | 15 slidesBlue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · Action1 hit
01
BNY Mellon | Results Presentation Deck | 18 slidesBNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Financial Highlights1 hit
02
Includes non-GAAP reconciliation footnotes.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Financial HighlightsLoop · Cost Of Inaction1 hit
03
Includes non-GAAP adjustments for notable items.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Financial HighlightsLoop · Cost Of Inaction1 hit
04
Includes footnotes referenced as (a) and (b).BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment PerformanceLoop · Cost Of Inaction1 hit
05
BNY Mellon | Results Presentation Deck | 18 slidesBNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment PerformanceLoop · Cost Of Inaction1 hit
06
Includes a non-GAAP reconciliation note regarding notable items.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
07
Includes footnotes referencing Appendix page 12.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
08
Includes footnotes reference to page 12.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
09
Includes footnotes regarding non-GAAP measures and specific reporting units.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
10
BNY Mellon | Results Presentation Deck | 18 slidesBNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Business Segment Performance1 hit
11
BNY Mellon | Results Presentation Deck | 18 slidesBNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit
12
BNY Mellon | Results Presentation Deck | 18 slidesBNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit
13
The slide presents three distinct sub-tables: total fee revenue impact, impact by line of business for investment services, and total impact to revenue by line of business.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit
14
Includes footnotes (a) through (d) explaining the nature of notable items and calculation methodologies.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit
15
Includes two distinct financial reconciliation tables.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit
16
Contains three distinct financial tables: margin reconciliation over time, reconciliation of notable items in 3Q22, and noninterest expense reconciliation.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit
17
Contains two distinct financial reconciliation tables.BNY Mellon | Results Presentation Deck | 18 slides · BNY Mellon
Conference presentation Investor relations Beat · Appendix1 hit